Decline of cosmetic outcomes following accelerated partial breast irradiation using intensity modulated radiation therapy: Results of a single-institution prospective clinical trial

Adam L. Liss, Merav A. Ben-David, Reshma Jagsi, James A. Hayman, Kent A. Griffith, Jean M. Moran, Robin B. Marsh, Lori J. Pierce*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose To report the final cosmetic results from a single-arm prospective clinical trial evaluating accelerated partial breast irradiation (APBI) using intensity modulated radiation therapy (IMRT) with active-breathing control (ABC). Methods and Materials Women older than 40 with breast cancer stages 0-I who received breast-conserving surgery were enrolled in an institutional review board-approved prospective study evaluating APBI using IMRT administered with deep inspiration breath-hold. Patients received 38.5 Gy in 3.85-Gy fractions given twice daily over 5 consecutive days. The planning target volume was defined as the lumpectomy cavity with a 1.5-cm margin. Cosmesis was scored on a 4-category scale by the treating physician. Toxicity was scored according to National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE version 3.0). We report the cosmetic and toxicity results at a median follow-up of 5 years. Results A total of 34 patients were enrolled. Two patients were excluded because of fair baseline cosmesis. The trial was terminated early because fair/poor cosmesis developed in 7 of 32 women at a median follow-up of 2.5 years. At a median follow-up of 5 years, further decline in the cosmetic outcome was observed in 5 women. Cosmesis at the time of last assessment was 43.3% excellent, 30% good, 20% fair, and 6.7% poor. Fibrosis according to CTCAE at last assessment was 3.3% grade 2 toxicity and 0% grade 3 toxicity. There was no correlation of CTCAE grade 2 or greater fibrosis with cosmesis. The 5-year rate of local control was 97% for all 34 patients initially enrolled. Conclusions In this prospective trial with 5-year median follow-up, we observed an excellent rate of tumor control using IMRT-planned APBI. Cosmetic outcomes, however, continued to decline, with 26.7% of women having a fair to poor cosmetic result. These results underscore the need for continued cosmetic assessment for patients treated with APBI by technique.

Original languageEnglish
Pages (from-to)96-102
Number of pages7
JournalInternational Journal of Radiation Oncology Biology Physics
Volume89
Issue number1
DOIs
StatePublished - 1 May 2014
Externally publishedYes

Funding

FundersFunder number
National Cancer InstituteP30CA046592

    Fingerprint

    Dive into the research topics of 'Decline of cosmetic outcomes following accelerated partial breast irradiation using intensity modulated radiation therapy: Results of a single-institution prospective clinical trial'. Together they form a unique fingerprint.

    Cite this